The EU Artificial Intelligence Act—the world’s first comprehensive regulatory framework for AI—will reshape how companies build, document, and protect innovations deployed in Europe. Although the Act was adopted in 2024, its major compliance obligations will phase in through 2026 and 2027, steadily expanding the scope of technical information companies must disclose to regulators. These mandatory disclosures, while designed to ensure safety and accountability, carry profound implications for patent protection, inventorship, and trade secret management.

A central challenge stems from the Act’s risk-tiered structure. High-risk AI systems—including those used in healthcare, employment, education, and critical infrastructure—must undergo a conformity assessment before entering the EU market. Providers must supply regulators with detailed technical documentation covering system architecture, datasets, testing methodologies, risk mitigation measures, and human oversight mechanisms. Providers of general-purpose and foundation models face additional obligations, such as preparing dataset summaries and providing systematic evaluations of model behavior.

For patent owners and practitioners, these requirements create a new disclosure risk: regulatory filings may reveal algorithmic or data-related details that overlap with potential patent applications. If submitted before a patent filing, such information may constitute a public disclosure that threatens novelty, undermines claim scope, or narrows enforceability. The Act also impacts trade secret strategies. Mandatory dataset summaries and technical files weaken confidentiality protections, shifting the calculus toward patenting innovations that can no longer be reliably maintained as secrets.

Takeaways

  • Regulatory disclosures may become prior art. Technical submissions must be sequenced to avoid prefiling exposure of inventive concepts.
  • Foundation-model documentation affects value. Dataset summaries and risk evaluations may reveal use of copyrighted or unlicensed data, creating litigation or freedom-to-operate risks that impact portfolio valuation.
  • Inventorship disputes become more complex. The Act’s recordkeeping obligations create evidentiary trails that may help delineate human inventive contributions from AI assistance—essential in jurisdictions recognizing only human inventors.
  • EU conformity assessments may constrain claim drafting. EU-aligned claims may need to be narrower than their U.S. counterparts to match certified system configurations.

Best Practices for Practitioners and IP Owners

  • Align patent filings with regulatory timelines; file before submitting documentation.
  • Use mixed protection strategies: patent where disclosure is unavoidable; maintain trade secrets only where confidentiality can be preserved.
  • Develop claim sets tailored separately for EU-regulated configurations and broader U.S. variants.
  • Conduct portfolio audits to identify assets intersecting with EU AI Act compliance obligations.
  • Integrate patent counsel into AI governance, compliance planning, and product design reviews.

Significant Developments

On November 19, 2025, the European Commission proposed a Digital Omnibus package to streamline several tech regulations. Notably, it recommended delaying certain high-risk AI Act obligations from August 2026 to December 2027, including requirements affecting biometric identification, road traffic applications, utilities management, job application and exam systems, health services, creditworthiness assessments, and law enforcement uses. The proposal also simplifies cookie consent rules. While still subject to debate and approval, the move reflects pressure from industry and international stakeholders—even as the Commission maintains that the AI Act’s overall framework remains robust.

Read the original article that appeared in Bloomberg Law, EU AI Act Demands Informed, Disclosure-Aware Patent Strategies.


This article appeared in the 2025 AI Intellectual Property: Analysis & Trends Year in Review report.

© 2026 Sterne, Kessler, Goldstein & Fox PLLC